Innovative UV Protocols Based on Straightforward Mathematical Filtration for Concurrent Estimation of Two Antidiabetic Drugs in Their Brand-New Combination: A Comparative Study

Earth-friendly-assessed UV-spectrophotometric approaches for concurrent determination of mirabegron and solifenacin succinate in different matrices

(2023) Rania A. Sayed et al.   Sustainable Chemistry and Pharmacy

Innovative earth-friendly UV-spectrophotometric technique for in-vitro dissolution testing of miconazole nitrate and nystatin in their vaginal suppositories: Greenness assessment

(2022) Ahmed R Mohamed et al.   JOURNAL OF AOAC INTERNATIONAL

Simple mathematical data processing method for the determination of sever overlapped spectra of linagliptin and empagliflozin in their pure forms and pharmaceutical formulation: Fourier self deconvulated method

(2021) Manal S. Elmasry et al.   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY

Smart UV-spectrophotometric platforms for rapid green analysis of miconazole nitrate and nystatin in their combined suppositories and in vitro dissolution testing

(2021) Rania A. Sayed et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Validated Voltammetric Method for the Simultaneous Determination of Anti‐diabetic Drugs, Linagliptin and Empagliflozin in Bulk, Pharmaceutical Dosage Forms andBiological Fluids

(2020) Mohamed Rizk et al.   ELECTROANALYSIS

Genetics of diabetes mellitus and diabetes complications

(2020) Joanne B. Cole et al.   Nature Reviews Nephrology

Stability‐indicating ultra performance liquid chromatography method development and validation for simultaneous estimation of metformin, linagliptin, and empagliflozin in bulk and pharmaceutical dosage form

(2020) Krishna Rao Vankalapati et al.   BIOMEDICAL CHROMATOGRAPHY

Flourimetric study on antidiabetic combined drugs; empagliflozin and linagliptin in their pharmaceutical formulation and human plasma

(2020) Manal S. Elmasry et al.   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY

Comparative Study Between Multivariate and Univariate Analysis of Two Antidiabetic Combinations

(2017) Maha F. Abdel-Ghany et al.   JOURNAL OF AOAC INTERNATIONAL

Empagliflozin/Linagliptin: Combination therapy in patients with type 2 diabetes

(2016) Xueying Tan et al.   ANNALES D ENDOCRINOLOGIE

Erratum. Initial Combination of Empagliflozin and Linagliptin in Subjects With Type 2 Diabetes. Diabetes Care 2015;38:394–402

(2015) Andrew Lewin et al.   DIABETES CARE

The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review

(2014) Janet B. McGill   Diabetes Therapy

Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment

(2013) Erika Paniago Guedes et al.   Diabetology & Metabolic Syndrome

Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature

(2009) L. Nalysnyk et al.   DIABETES OBESITY & METABOLISM

Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes

(2009) Carolyn F Deacon et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS